These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
329 related articles for article (PubMed ID: 1665372)
21. Implications of biological aging to the optometric patient. Rumsey KE J Am Optom Assoc; 1988 Apr; 59(4 Pt 1):295-300. PubMed ID: 3397477 [TBL] [Abstract][Full Text] [Related]
22. Aging issues in drug disposition and efficacy. Sitar DS Proc West Pharmacol Soc; 2007; 50():16-20. PubMed ID: 18605223 [TBL] [Abstract][Full Text] [Related]
23. Intestinal response in aging: changes in reserve capacity. Pénzes L Acta Med Hung; 1984; 41(4):263-77. PubMed ID: 6393034 [TBL] [Abstract][Full Text] [Related]
24. Effects of aging on pharmacokinetic and pharmacodynamic drug processes. Howland RH J Psychosoc Nurs Ment Health Serv; 2009 Oct; 47(10):15-6, 17-8. PubMed ID: 19835315 [TBL] [Abstract][Full Text] [Related]
25. Age-related physiological changes and their clinical significance. Boss GR; Seegmiller JE West J Med; 1981 Dec; 135(6):434-40. PubMed ID: 7336713 [TBL] [Abstract][Full Text] [Related]
26. Age-dependent changes of the kidneys: pharmacological implications. Mühlberg W; Platt D Gerontology; 1999; 45(5):243-53. PubMed ID: 10460985 [TBL] [Abstract][Full Text] [Related]
30. Drug therapy in the elderly. Turnheim K Exp Gerontol; 2004; 39(11-12):1731-8. PubMed ID: 15582289 [TBL] [Abstract][Full Text] [Related]
31. Development of a Whole-Body Physiologically Based Pharmacokinetic Approach to Assess the Pharmacokinetics of Drugs in Elderly Individuals. Schlender JF; Meyer M; Thelen K; Krauss M; Willmann S; Eissing T; Jaehde U Clin Pharmacokinet; 2016 Dec; 55(12):1573-1589. PubMed ID: 27351180 [TBL] [Abstract][Full Text] [Related]
32. [The significance of age dependent organ changes for therapy]. Platt D Aktuelle Gerontol; 1982 Nov; 12(6):220-2. PubMed ID: 6130716 [TBL] [Abstract][Full Text] [Related]
33. Medications in older patients. Hobson M West J Med; 1992 Nov; 157(5):539-43. PubMed ID: 1309183 [TBL] [Abstract][Full Text] [Related]
34. The influence of cardiovascular physiology on dose/pharmacokinetic and pharmacokinetic/pharmacodynamic relationships. Fagiolino P; Eiraldi R; Vázquez M Clin Pharmacokinet; 2006; 45(5):433-48. PubMed ID: 16640451 [TBL] [Abstract][Full Text] [Related]
35. Do we need different treatments for very elderly COPD patients? Valente S; Pasciuto G; Bernabei R; Corbo GM Respiration; 2010; 80(5):357-68. PubMed ID: 20733280 [TBL] [Abstract][Full Text] [Related]
36. Age-related changes in protein binding of drugs: implications for therapy. Grandison MK; Boudinot FD Clin Pharmacokinet; 2000 Mar; 38(3):271-90. PubMed ID: 10749520 [TBL] [Abstract][Full Text] [Related]
37. Alterations in neural cardiovascular control mechanisms with ageing. Giannattasio C; Ferrari AU; Mancia G J Hypertens Suppl; 1994 Sep; 12(6):S13-7. PubMed ID: 7799104 [TBL] [Abstract][Full Text] [Related]
38. [Side-effects of drugs on the digestive system in old age]. Zdichynec B Cesk Gastroenterol Vyz; 1981 Mar; 35(2):57-67. PubMed ID: 7011580 [No Abstract] [Full Text] [Related]
39. Predicting effective drug concentrations for individual patients. Determinants of pharmacodynamic variability. Levy G Clin Pharmacokinet; 1998 Apr; 34(4):323-33. PubMed ID: 9571304 [TBL] [Abstract][Full Text] [Related]
40. Pharmacology of anticancer drugs in the elderly population. Wildiers H; Highley MS; de Bruijn EA; van Oosterom AT Clin Pharmacokinet; 2003; 42(14):1213-42. PubMed ID: 14606930 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]